SEC Tracker
Get the app

Hepion Pharmaceuticals HEPA

Hepion Pharmaceuticals: preliminary information statement (shareholder action already approved)

Form
PRE 14C
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

Preliminary information statement (shareholder action already approved)

View on EDGAR

Open in the app

Get an email when Hepion Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. International Stem Cell ISCO public float $592K, Jun 30, 2025
  2. Emmaus Life Sciences EMMA public float $582K, Jun 30, 2025
  3. NovAccess Global XSNX public float $338K, Mar 31, 2025, over 18 months old
  4. CNBX Pharmaceuticals CNBX public float $252K, Aug 31, 2025
  5. ProtoKinetix PKTX public float $2M, Jun 30, 2026